116 related articles for article (PubMed ID: 25635966)
1. Effect of posterior subtenon injection of 40 mg of triamcinolone acetonide on glycemic control and serum cortisol and adrenocorticotropic hormone in diabetic patients.
Yolcu Ü; Ilhan A
Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):1. PubMed ID: 25635966
[No Abstract] [Full Text] [Related]
2. Effect of posterior subtenon injection of 40 mg of triamcinolone acetonide on glycemic control and serum cortisol and adrenocorticotropic hormone in diabetic patients.
Kaderli B; Kivanc SA; Inan UU; Ersoy C; Yucel AA; Yilmaz S; Avci R
Eur Rev Med Pharmacol Sci; 2014; 18(18):2609-14. PubMed ID: 25317793
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.
Choi YJ; Oh IK; Oh JR; Huh K
Korean J Ophthalmol; 2006 Dec; 20(4):205-9. PubMed ID: 17302204
[TBL] [Abstract][Full Text] [Related]
4. Systemic complications of posterior subtenon injection of triamcinolone acetonide in type 2 diabetes patients.
Toda J; Fukushima H; Kato S
Diabetes Res Clin Pract; 2009 May; 84(2):e38-40. PubMed ID: 19233498
[TBL] [Abstract][Full Text] [Related]
5. Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.
Kim MW; Moon H; Yang SJ; Joe SG
Korean J Ophthalmol; 2016 Feb; 30(1):25-31. PubMed ID: 26865800
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
7. Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
Salti H; Farah T
Am J Ophthalmol; 2005 Nov; 140(5):958; author reply 958-9. PubMed ID: 16310498
[No Abstract] [Full Text] [Related]
8. Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
Bakri SJ; Kaiser PK
Am J Ophthalmol; 2005 Feb; 139(2):290-4. PubMed ID: 15733990
[TBL] [Abstract][Full Text] [Related]
9. Posterior subtenon injection of triamcinolone acetonide after phacoemulsification in a patient with X-linked retinoschisis.
Wang JK; Lin WC
Optom Vis Sci; 2013 Oct; 90(10):e274-7. PubMed ID: 23974665
[TBL] [Abstract][Full Text] [Related]
10. The effect of subtenon triamcinolone acetonide injection for diabetic macular edema on retinal and choroidal circulation.
Mawatari Y; Koga T; Inumaru J; Hirata A; Fukushima M; Tanihara H
Am J Ophthalmol; 2005 Nov; 140(5):948-9. PubMed ID: 16310489
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal Bioerudivel sustained-release triamcinolone microspheres system (RETAAC). Preliminary report of its potential usefulnes for the treatment of diabetic macular edema.
Cardillo JA; Souza-Filho AA; Oliveira AG
Arch Soc Esp Oftalmol; 2006 Dec; 81(12):675-7, 679-81. PubMed ID: 17199160
[No Abstract] [Full Text] [Related]
12. Vessel diameter study: intravitreal vs posterior subtenon triamcinolone acetonide injection for diabetic macular edema.
Kurt MM; Çekiç O; Akpolat Ç; Aslankurt M; Elçioğlu M
Eye (Lond); 2017 Aug; 31(8):1155-1162. PubMed ID: 28338665
[TBL] [Abstract][Full Text] [Related]
13. Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edema.
Shimura M; Yasuda K; Minezaki T; Noma H
Jpn J Ophthalmol; 2016 Sep; 60(5):401-7. PubMed ID: 27306783
[TBL] [Abstract][Full Text] [Related]
14. Scedosporium apiospermum infectious scleritis following posterior subtenon triamcinolone acetonide injection: a case report and literature review.
Todokoro D; Hoshino J; Yo A; Makimura K; Hirato J; Akiyama H
BMC Ophthalmol; 2018 Feb; 18(1):40. PubMed ID: 29433463
[TBL] [Abstract][Full Text] [Related]
15. [Secondary adrenal insufficiency after local injections of triamcinolone acetonide].
Schott S; Schnauder G; Müssig K
Dtsch Med Wochenschr; 2009 Feb; 134(7):298-301. PubMed ID: 19197811
[TBL] [Abstract][Full Text] [Related]
16. Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide.
Chan LW; Hsu WC; Hsieh YT
J Glaucoma; 2016 Mar; 25(3):e268-72. PubMed ID: 26950466
[TBL] [Abstract][Full Text] [Related]
17. Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema.
Yu SY; Nam DH; Lee DY
Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):39-47. PubMed ID: 29030692
[TBL] [Abstract][Full Text] [Related]
18. Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema.
Ozkurt YB; Akkaya S; Aksoy S; Evciman T; Haboğlu M
J Ocul Pharmacol Ther; 2015 Oct; 31(8):455-60. PubMed ID: 26154736
[TBL] [Abstract][Full Text] [Related]
19. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
[TBL] [Abstract][Full Text] [Related]
20. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I
Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
